Eric V Li, Sai Kumar, Jonathan A Aguiar, Mohammad R Siddiqui, Zequn Sun, Clayton Neill, Edward M Schaeffer, Ashley E Ross, Hiten D Patel
{"title":"Prostate MRI and clinicopathologic risk calculator to predict laterality of extraprostatic extension at radical prostatectomy.","authors":"Eric V Li, Sai Kumar, Jonathan A Aguiar, Mohammad R Siddiqui, Zequn Sun, Clayton Neill, Edward M Schaeffer, Ashley E Ross, Hiten D Patel","doi":"10.1038/s41391-024-00928-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Traditional nomograms can inform the presence of extraprostatic extension (EPE) but not laterality, which remains important for surgical planning, and have not fully incorporated multiparametric MRI data. We evaluated predictors of side-specific EPE on surgical pathology including MRI characteristics and developed side-specific EPE risk calculators.</p><p><strong>Methods: </strong>This was a retrospective cohort of patients evaluated with mpMRI prior to radical prostatectomy (RP) in our eleven hospital healthcare system from July 2018-November 2022. The dominant side was defined pre-operatively using a tiered system based on laterality of highest biopsy Gleason Grade Group (GG), highest PIRADS lesion, number of lesions, and cancer volume. Univariable and multivariable logistic regression were performed for overall EPE, dominant side EPE, and non-dominant side EPE. Internal validation with leave one out and calibration curves were completed.</p><p><strong>Results: </strong>EPE was identified in 53% (317/601) of patients at RP. Side-specific factors (PIRADS, GG, abutment) were only associated with EPE on their respective side. Final variables in the model associated with EPE on the dominant and non-dominant sides included age, log PSA density (PSAD), side-specific PIRADS 5, side-specific GG3-5, and percentage positivity of systematic cores. AUCs for dominant and non-dominant side EPE were 0.77 (95% CI 0.73-0.80) and 0.79 (95% CI 0.74-0.84), respectively. MRI-identified abutment and prostate health index (PHI) did not improve model discrimination. Risk calculators available online at https://rossnm1.shinyapps.io/PredictionOfEPELaterality/ .</p><p><strong>Conclusions: </strong>PSA, side-specific PIRADS, side-specific GG, and percentage positivity of systematic cores were associated with side-specific EPE at RP and incorporated into a risk calculator to assist in surgical planning and nerve-sparing decisions at time of RP.</p>","PeriodicalId":20727,"journal":{"name":"Prostate Cancer and Prostatic Diseases","volume":" ","pages":""},"PeriodicalIF":5.8000,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prostate Cancer and Prostatic Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41391-024-00928-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Traditional nomograms can inform the presence of extraprostatic extension (EPE) but not laterality, which remains important for surgical planning, and have not fully incorporated multiparametric MRI data. We evaluated predictors of side-specific EPE on surgical pathology including MRI characteristics and developed side-specific EPE risk calculators.
Methods: This was a retrospective cohort of patients evaluated with mpMRI prior to radical prostatectomy (RP) in our eleven hospital healthcare system from July 2018-November 2022. The dominant side was defined pre-operatively using a tiered system based on laterality of highest biopsy Gleason Grade Group (GG), highest PIRADS lesion, number of lesions, and cancer volume. Univariable and multivariable logistic regression were performed for overall EPE, dominant side EPE, and non-dominant side EPE. Internal validation with leave one out and calibration curves were completed.
Results: EPE was identified in 53% (317/601) of patients at RP. Side-specific factors (PIRADS, GG, abutment) were only associated with EPE on their respective side. Final variables in the model associated with EPE on the dominant and non-dominant sides included age, log PSA density (PSAD), side-specific PIRADS 5, side-specific GG3-5, and percentage positivity of systematic cores. AUCs for dominant and non-dominant side EPE were 0.77 (95% CI 0.73-0.80) and 0.79 (95% CI 0.74-0.84), respectively. MRI-identified abutment and prostate health index (PHI) did not improve model discrimination. Risk calculators available online at https://rossnm1.shinyapps.io/PredictionOfEPELaterality/ .
Conclusions: PSA, side-specific PIRADS, side-specific GG, and percentage positivity of systematic cores were associated with side-specific EPE at RP and incorporated into a risk calculator to assist in surgical planning and nerve-sparing decisions at time of RP.
背景:传统的x线图可以显示前列腺外展(EPE)的存在,但不能显示侧位,这对于手术计划仍然很重要,并且尚未完全纳入多参数MRI数据。我们评估了侧位特异性EPE的手术病理学预测因素,包括MRI特征,并开发了侧位特异性EPE风险计算器。方法:这是一项回顾性队列研究,研究对象是2018年7月至2022年11月在我们的11家医院医疗系统中接受根治性前列腺切除术(RP)前进行mpMRI评估的患者。术前根据最高活检Gleason分级组(GG)的侧边、最高PIRADS病变、病变数量和癌体积分层系统确定优势侧。对总体EPE、优势侧EPE和非优势侧EPE进行单变量和多变量logistic回归。完成了留1的内部验证和校准曲线。结果:53%(317/601)的RP患者出现EPE。侧特异性因素(PIRADS, GG,基台)仅与各自侧的EPE相关。模型中与优势侧和非优势侧EPE相关的最终变量包括年龄、对数PSA密度(PSAD)、侧特异性PIRADS 5、侧特异性GG3-5和系统岩心阳性率。优势侧和非优势侧EPE的auc分别为0.77 (95% CI 0.73-0.80)和0.79 (95% CI 0.74-0.84)。mri识别的基台和前列腺健康指数(PHI)并没有改善模型识别。结论:PSA、侧特异性PIRADS、侧特异性GG和系统核心阳性百分比与RP时的侧特异性EPE相关,并纳入风险计算器,以协助RP时的手术计划和神经保留决策。
期刊介绍:
Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management.
Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, male LUTS and prostatitis.
Prostate Cancer and Prostatic Diseases publishes original research articles, reviews, topical comment and critical appraisals of scientific meetings and the latest books. The journal also contains a calendar of forthcoming scientific meetings. The Editors and a distinguished Editorial Board ensure that submitted articles receive fast and efficient attention and are refereed to the highest possible scientific standard. A fast track system is available for topical articles of particular significance.